J Kaliman

710 total citations
78 papers, 513 citations indexed

About

J Kaliman is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pharmacology. According to data from OpenAlex, J Kaliman has authored 78 papers receiving a total of 513 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Cardiology and Cardiovascular Medicine, 18 papers in Surgery and 16 papers in Pharmacology. Recurrent topics in J Kaliman's work include Antiplatelet Therapy and Cardiovascular Diseases (24 papers), Inflammatory mediators and NSAID effects (13 papers) and Cardiac pacing and defibrillation studies (8 papers). J Kaliman is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (24 papers), Inflammatory mediators and NSAID effects (13 papers) and Cardiac pacing and defibrillation studies (8 papers). J Kaliman collaborates with scholars based in Austria, Germany and Russia. J Kaliman's co-authors include H. Sinzinger, H Sinzinger, P Fitscha, A. Oguogho, John O’Grady, G. Schernthaner, K Silberbauer, Peter Probst, Kurt Widhalm and Thomas Zidek and has published in prestigious journals such as Circulation, European Heart Journal and British Journal of Clinical Pharmacology.

In The Last Decade

J Kaliman

76 papers receiving 481 citations

Peers

Countries citing papers authored by J Kaliman

Since Specialization

Citations

This map shows the geographic impact of J Kaliman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Kaliman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Kaliman more than expected).

Fields of papers citing papers by J Kaliman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Kaliman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Kaliman. The network helps show where J Kaliman may publish in the future.

Co-authorship network of co-authors of J Kaliman

This figure shows the co-authorship network connecting the top 25 collaborators of J Kaliman. A scholar is included among the top collaborators of J Kaliman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Kaliman. J Kaliman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Eicosanoid production and lymphatic responsiveness in human cigarette smokers compared with non-smokers. 2000 ·PubMed ·H. Sinzinger, J Kaliman, A. Oguogho	12
2	Eicosanoid generation and responsiveness of human lymphatics in hyperlipoproteinemia 2000 ·Prostaglandins Leukotrienes and Essential Fatty Acids ·A. Oguogho, J Kaliman, H. Sinzinger	5
3	PLATELET RESPONSE DURING PROSTAGLANDIN E 1 -THERAPY IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES MELLITUS 1997 ·Thrombosis Research ·Harald Kritz, A. Oguogho, P Fitscha, J Kaliman, W. Rogatti, H. Sinzinger	2
4	Platelet lipoxygenase defect (wien‐penzing defect) in two patients with myocardial infarction 1991 ·American Journal of Hematology ·(unknown), J Kaliman, John O’Grady	18
5	Determinants of Subsidiary Ventricular Pacemaker Suppression in Man 1991 ·Pacing and Clinical Electrophysiology ·Herwig Schmidinger, Peter Probst, Barbara Schneider, H. Wéber, J Kaliman	4
6	Additive benefit of PGI2 and PGE1 (via different mechanisms?) on inhibition of activation of human vascular smooth muscle cells? 1990 ·Experimental Pathology ·H. Sinzinger, P Fitscha, Otto Wagner, J Kaliman, Thomas Zidek, W. Rogatti	6
7	Beneficial effect of long-term PGE1-treatment in left ventricular heart failure 1989 ·Prostaglandins Leukotrienes and Essential Fatty Acids ·Irene Virgolini, J Kaliman, P Fitscha, John O’Grady, W. Rogatti, H. Sinzinger	17
8	Humoral regulation during cold-induced coronary arterial spasm 1989 ·International Journal of Cardiology ·Thomas Stefenelli, (unknown), Heinz Sochor, Dietmar Glogar, J Kaliman	4
9	In vivo modulation of platelet deposition on human atherosclerotic lesions by various antiaggregatory prostaglandins. 1988 ·PubMed ·P Fitscha, J Kaliman, John O’Grady, H Sinzinger	4
10	Comparable effect of prostaglandin E1 in decreasing in vivo platelet deposition on human lesion sites after intravenous and intraarterial application 1988 ·Thrombosis Research ·H. Sinzinger, John O’Grady, P Fitscha, (unknown), J Kaliman	15
11	Stimulation of prostacyclin formation by the platelet-derived growth factor — an important pathomechanism for atherogenesis? 1988 ·Experimental Pathology ·H. Sinzinger, Thomas Zidek, J Kaliman	5
12	Epoprostenol in patients with Raynaud's disease 1988 ·Prostaglandins Leukotrienes and Essential Fatty Acids ·P Fitscha, J Kaliman, Franz Weidinger, (unknown), John Patrick O’Grady	2
13	Rate Dependent Depression of Subsidiary Ventricular Impulse Formation—Cause of Stokes‐Adams Attacks in a Patient with Rate Modulated Pacing 1988 ·Pacing and Clinical Electrophysiology ·Herwig Schmidinger, Peter Probst, H. Wéber, J Kaliman	4
14	Survival rate and causes of death in patients with pacemakers: dependence on symptoms leading to pacemaker implantation 1988 ·European Heart Journal ·Ch. Müller, (unknown), Dietmar Glogar, A. Laczkovics, Hannah L. Mayr, (unknown), Herwig Schmidinger, Ernst Schuster, Kamil Sedláček, J Kaliman	26
15	[Return to work following myocardial infarct]. 1988 ·PubMed ·F Rauscha, Carsten Müller, Herbert Kiss, J Mlczoch, Jennifer E. Schuster, H. Wéber, J Kaliman	4
16	Clinical benefit and prolongation of platelet half-life induced by CG 4203, a stable PGI2-analogue. 1987 ·PubMed ·J Kaliman, P Fitscha, Harald Barth, H Sinzinger	2
17	Prostacyclin synthesis stimulating plasma factor in patients with peripheral vascular disease 1987 ·Prostaglandins Leukotrienes and Medicine ·(unknown), P Fitscha, J Kaliman, H. Sinzinger, Bernhard A. Peskar	5
18	Prostaglandin 12 reduces activation of human arterial smooth muscle cells in-vivo 1987 ·Prostaglandins ·(unknown), Thomas Zidek, P Fitscha, John O’Grady, Otto Wagner, J Kaliman	26
19	[Guidelines for the prevention of atherosclerosis]. 1987 ·PubMed ·J Kaliman, Gerhard M. Kostner, O. Kraupp, (unknown), H. Sinzinger, Kurt Widhalm	4
20	Electrophysiologic Findings in Carotid Sinus Massage 1983 ·Pacing and Clinical Electrophysiology ·Peter Probst, V. Mühlberger, (unknown), Otmar Pachinger, J Kaliman, (unknown)	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact